Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NCT07022587
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
2000
Enrollment
OTHER
Sponsor class
Conditions
De Novo Stenosis
Coronary Artery Disease
Interventions
DEVICE:
Sirolimus-eluting bioresorbable scaffolds
DEVICE:
Sirolimus-eluting stents
Sponsor
Xijing Hospital